Efficacy and safety of rifaximin in patients with chronic intestinal pseudo-obstruction: a randomized, double-blind, placebo-controlled, phase II-a exploratory trial.
Ohkubo H, Kessoku T, Tanaka K, Takahashi K, Takatsu T, Yoshihara T, Misawa N, Ashikari K, Fuyuki A, Kato S, Higurashi T, Hosono K, Yoneda M, Misumi T, Shinoda S, Stanghellini V, Nakajima A.
Ohkubo H, et al. Among authors: shinoda s.
Biosci Microbiota Food Health. 2024;43(2):135-144. doi: 10.12938/bmfh.2023-080. Epub 2023 Dec 27.
Biosci Microbiota Food Health. 2024.
PMID: 38562545
Free PMC article.